Objective: To explore the association of DLGAP1 gene with executive function (EF) in attention deficit hyperactivity disorder (ADHD) children.
| INTRODUCTION
Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent psychiatric disorders in childhood, which is characterized by hyperactivity, impulsivity, and inattention. The heritability of ADHD is approximately 76% (Faraone & Mick, 2010) . Children with ADHD often have executive function (EF) deficits (Barkley, 2010; Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005) , including impairment in inhibitory control, working memory, and cognitive flexibility. In recent years, there are many reports about EFs as endophenotype for ADHD (Gau & Shang, 2010) . Endophenotype may reduce the heterogeneity of complex neuropsychiatric disorders (Doyle et al., 2008; Rommelse, 2008) . A recent meta-analyses also indicated that some EF impairment was shared across disorders (Snyder, Miyake, & Hankin, 2015) . EF refers to a collection of cognitive function. It was a highly heritable trait (Friedman & Miyake, 2017; Friedman et al., 2008) .
Many genes involved in several neurotransmitter or neuromodulator systems (Darvas & Palmiter, 2015) , including glutamatergic, cholinergic (Ragozzino, Mohler, Prior, Palencia, & Rozman, 2009; Wang et al., 2013) , serotonergic (Clarke et al., 2005) , and dopaminergic signaling (Darvas, Henschen, & Palmiter, 2014; De Steno & Schmauss, 2009) , were reported to be associated with EF.
DLGAP1, located on chromosome 18p11.31, which is also known as SAP90/PSD-95-associated protein (SAPAP) encoding the guanylate kinase-associated protein (GKAP), was involved in the pathophysiology of several psychiatric disorders, such as obsessive-compulsive disorder (OCD), schizophrenia (SCZ), major depression disorder (MDD), and Alzheimer's disease (AD; Bertram et al., 2008; Mathias et al., 2016) . Although there is no report about the association of DLGAP1 with ADHD, as ADHD shares some genetic basis with other psychiatric disorders, and all these disorders were reported to have impaired cognitive function (Ebmeier, Donaghey, & Steele, 2006; Francazio & Flessner, 2015; Pooragha, Kafi, & Sotodeh, 2013; Thoma, Wiebel, & Daum, 2007) , it is valuable to explore the association of DLGAP1 with ADHD through the underlying impaired cognitive function.
The protein SAPAP1 encoded by DLGAP1 interacts with PSD95, which is encoded by DLG4 and has been reported to be a predictor of cognitive deficits (Sultana, Banks, & Butterfield, 2009; Whitfield et al., 2014) . SAPAPs constitute the member of the N-methyl-d aspartate (NMDA) receptor-associated postsynaptic density proteins.
The latter had been showed for potential association with ADHD for its significant role in prefrontal cortex activity and cognitive function (Chang, Lane, & Tsai, 2014; Lehohla, Kellaway, & Russell, 2004 ). For ADHD model of spontaneously hypertensive rat (SHR), impaired NMDA receptor function in the prefrontal cortex could result in cognitive deficits and an inability to sustaining attention (Lehohla et al., 2004) . So the DLGAP1 may play a role in cognition through DLGAP1-DLG4-NMDA complex.
In this study, we firstly compared the difference of several executive function measures among patients with ADHD and controls.
Then, we explored the associations between DLGAP1 variants and performance on the EF relevant measures and further connected with ADHD symptoms to uncover potential genetic mechanisms underlying EF deficit in ADHD individuals. Set-based analyses for gene and gene-related pathway were also performed to confirm the association.
| MATERIALS AND METHODS

| Participants
All subjects were from the Han Chinese ADHD GWAS project (Yang et al., 2013) . Samples were consecutively collected from the child psychiatric outpatient department of Peking University Sixth Hospital. Patients met the diagnostic criteria for ADHD defined by the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV).
The recruitment procedure of both ADHD cases and controls had been described in our previous publication. In addition, we collected symptom score for the patients with ADHD according to the Clinical Diagnostic Interview Scale (Barkley, 2006) to characterize the severity of the patients. This study was approved by the Institutional Review Board of Peking University Six Hospital. All the parents signed a written informed consent.
| Executive function test
As previous literature reported, the children with ADHD showed significant deficits in inhibition, working memory, cognitive flexibility, and plan, and they often were thought to be potential endophenotypes for ADHD (Gau & Shang, 2010; Willcutt et al., 2005) . In this study, we conducted digit span test, Trail Making Test (TMT), Stroop test, and Tower of Hanoi on subjects to examine working memory, cognitive flexibility, inhibition, and plan separately.
| Trail making test (TMT)
We used TMT to assess cognitive flexibility (Shuai, Chan, & Wang, 2011) . The test consisted of two sections (A and B). In section A, the subject was asked to sequentially connect numbers (1-25) randomly scattered on a sheet as quickly as possible. In section B, the subject was asked to connect numbers and letters alternately (i.e., 1->A->2->B->3->C, … L->13; Rane et al., 2016) . When the subject made an error, the investigator pointed out immediately before proceeding the test. The times on section A mainly indicated visuoperceptual ability, attention, and motor speed, while that on section B involved set-shifting. The shifting time was got by the time for section B subtracting that for section A (Anderson, 2001; Sanchez-Cubillo et al., 2009) . Totally, 763 patients with ADHD and 140 normal controls completed TMT.
| Tower of Hanoi (TOH)
This task assesses planning and problem-solving (Bull et al., 2004) .
Three parallel bars were seated in a board. In the initial position, three disks of different size were put on the left bar with the largest on the bottom and the smallest on the top. The participant was required to move the disk from the left bar to the right bar forming the same tower as beginning. Only one disk could be moved at a time. Bigger disk could not be placed on a smaller one. Total time (TOTIM) to complete the task was recorded. In total, 519 patients with ADHD and 117 normal controls completed TOH.
| Stroop test
This task was used to assess inhibition function (Shuai et al., 2011) .
It included four sessions. Thirty stimuli were presented in a 10 × 3 matrix for three cards each (21 × 29.7 cm). In the first session, the subjects were asked to read the color words (red, green, yellow, and blue) printed in black ink. In the second session, they were asked to name the colored squares (red, green, yellow, and blue). In the third session, the subjects were asked to read the color words printed in different colors. In the fourth session, they were asked to name the colors of the ink. The time required to complete each session was recorded.
The color interference time (CIT) equals to the time to complete session 3 minus that for session 1, whereas the word interference time (WIT) equals to the time to complete session 4 minus that for session 2. Totally, 779 patients with ADHD and 140 normal controls completed Stroop Test.
| Digit span
This test was used to measure working memory, which was extracted from the Chinese-Wechsler Intelligence Scale for Children (C-WISC). The examiner read a series of digit at a rate of one digit per second, and then, the subjects were asked to repeat the digit forward or backward. The length of the digits increased when the participant completed one. The longest digit number achieved was recorded for the forward part and the backward part separately (Trampush, Jacobs, Hurd, Newcorn, & Halperin, 2014) . In total, 780 patients with ADHD and 82 normal controls completed digit span test.
| Genotyping
Genomic DNA was extracted from peripheral blood using Omega DNA extraction Kit (Omega Bio-tek Inc., Doraville, GA). Genotyping was performed using the Affymetrix 6.0 array in CapitalBio Inc. (Beijing, China). We extracted the genotype data of SNPs within gene DLGAP1. Individuals with call rates <98% or missing IQ, sex, and age information were removed. SNPs with call rate <95%, Hardy-Weinberg equilibrium test p < .001, or minor allele frequency <1% were removed.
Finally, 330 SNPs were remained for association analyses.
| Statistics analyses
Comparisons of sex, age, IQ between ADHD and control groups were using chi-squared or Student's t test as appropriately. The differences in executive function measures between ADHDs and controls were analyzed using the analysis of covariance (ANCOVA), with IQ, sex, and age as covariates. As the sample size of controls was much smaller than cases, we also randomly selected the same number of cases with the number of controls for each executive function meas- (http://pngu.mgh.harvard.edu/~purcell/plink/, RRID: SCR_001757), with the above covariates. The p-value of SNP was adjusted by Bonferroni correction by multiplying the number of SNPs we tested. To present the regional plot, the nongenotyped SNPs within DLGAP1 were imputed using MACH-admix 1.0 (http://www.unc.edu/~yunmli/MaCH-Admix/, RRID:SCR_009598; Liu, Li, Wang, & Li, 2013) using the ASN data (286 individuals) from the 1000 Genomes Project Integrated Phase 1 Release 37 as the reference panel. Imputed SNPs with a squared correlation between imputed and true genotypes (rsq) <0.6 or SNPs with minor allele frequency <0.01 were removed. Set-based association analysis for DLGAP1 was conducted for all 330 SNPs within gene DLGAP1 using the −set-test in PLINK. Default parameters for the max #SNPs, r-squared, and p-value were used (−set-max 5, −set-r 2 .5, −setp .05). Nine genes (DLGAP1, DLG4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, and GRIN3B) were included in pathway DLGAP1-DLG4-NMDA (Stephenson, 2006) . Totally 700 SNPs within these nine genes were used for the set-based analysis of this pathway using the −set-test in PLINK. The max #SNPs was set to 30; other parameters were as default.
| Functional analysis
To explore the function of the significant SNP on the expression of 
| RESULTS
| Executive function feature in ADHD children
We collected the Tb-Ta time in TMT for 763 patients with ADHD and 140 normal controls. Figure S1 . The first principle component was mainly related to Tb-Ta time and TOH time, while the second principle component was mainly related to CIT and WIT. DSDB and DSDF could not be differentiated using these two PCs.
| Association between DLGAP1 gene and components of executive function
As the small sample size of controls, the association analysis was performed only in cases. Association analysis for the 330
SNPs within gene DLGAP1 with the shifting time in 763 ADHD children identified two SNPs (rs2049161, p = 5.08e-7, adjusted p = 1.63e-4, rs16946051, p = 5.18e-7, adjusted p = 1.66e-4) to be significant after Bonferroni multiple testing correction ( Table 2, the regional plot is shown in Figure 1 ). These two SNPs were in high LD (r 2 > .8). Association analyses of the above two SNPs with another five executive function measures showed these two SNPs were associated with the TOH total time (p = 6.81e-4 for rs2049161, p = 7.91e-4 for rs16946051, Table 2 
| Association of DLGAP1 with ADHD symptoms
To test whether the DLGAP1 SNPs associated with cognitive flexibility were also associated with ADHD and ADHD symptom, we extracted the p-values of these two significant SNPs in PGC ADHD data set and our Han Chinese ADHD data set (Yang et al., 2013) . We also tested the association of them with ADHD symptom total score. All these SNP level results were not significant (p > .05). The set-based analysis result showed significance for the association of gene DLGAP1 with the total score of ADHD symptom (p = .0481). When we enlarged the parameters of set-based analysis (set −sex-max 50, −set-r 2 .3 and − set-p .1) to include more SNPs, the set-based analysis for the pathway DLGAP1-DLG4-NMDA also showed significance in ADHD symptom score (p = .0313).
| Function of the variants and gene
We searched the eQTL data for the two significant SNPs to explore whether they regulated the expression of DLGAP1. We found the T A B L E 1 Comparison of characteristics and performance on executive function tests between ADHD and control groups different alleles of these two SNPs had significant effect on the expression of DLGAP1 in medulla ( Figure S2 ). eQTL data for all SNPs with high LD (r 2 > .8) with the significant SNP rs2049161 showed these SNPs were also correlated to the expression of DLGAP1 in frontal cortex (Table S1 ). In normal samples, DLGAP1 gene was mainly expressed in brain. The highest expression level was found in frontal cortex ( Figure S3a ). We further checked the expression of DLGAP1 in different brain region in BRAINEAC. The regions with the highest T A B L E 2 Association result for SNP rs2049161 and rs16946051 with shifting time in TMT and total time for TOH (124) Freq is the allele frequency of the SNP in those samples with TMT or TOH result. L95 is the lower boundary of 95% confidence interval of BETA; U95 is the upper boundary of 95% confidence interval of BETA.
F I G U R E 1 Regional plot for SNP rs2049161, rs16946051 in DLGAP1. The SNPs after imputation were also plotted expression level included temporal cortex, frontal cortex, and occipital cortex ( Figure S3b) . The variant we identified may regulate the expression of DLGAP1 and further contribute to cognitive flexibility dysfunction.
| DISCUSSION
In this study, we firstly detected the deficit of cognitive flexibility and inhibition in our ADHD sample as expected, which had been consistently reported in previous studies (Paloscia et al., 2013) . But we did not found this difference in our sample in working memory and plan, which might be due to our small sample size, especially small control sample size.
Then, we explored the association between DLGAP1 and EF in children with ADHD. We identified two significant SNPs of DLGAP1 with cognitive flexibility. The association was also observed for the time to complete the TOH. The TOH mainly evaluate planning, which is one of a high-order EF, including the component of cognitive flexibility (Diamond, 2013) . During the test of TOH, participants should shift between subgoals to achieve the final goal in the test. showed diversity component (Friedman & Miyake, 2017) . So the components of EF might have different genetic contributors. Our results provided evidence that the diversity components might have different genetic influences, and different sets of genes might contribute to the various EF, which further distinguish cognitive function. This is coincidence within first twin study of latent EF variables (Friedman et al., 2008) .
We further checked the association of DLGAP1 and pathway DLGAP1-DLG4-NMDA with ADHD symptom. The result showed significant association of them with ADHD symptom score. The ADHD symptom was related to inhibition, shifting, and emotional regulation (Chhabildas, Pennington, & Willcutt, 2001; Riccio, Homack, Jarratt, & Wolfe, 2006; Toplak et al., 2009) . The association of DLGAP1 with ADHD symptom might be mediated by its effect on cognitive function.
The expression data for DLGAP1 support its function in brain.
The two SNPs found significantly associated with cognitive flexibility had significant effect on the expression of DLGAP1 in medulla.
A noradrenaline projection from medulla to nucleus accumbens was reported to play a role in stress response and behavioral flexibility (Stahl) . Besides these two SNPs, those in LD with them were found to regulate the expression of DLGAP1 in frontal cortex, which is consistent with the report that genes involved in synaptic signaling or plasticity in prefrontal cortex (PFC) had been implicated in cognition (Logue & Gould, 2013) . And in the recent review about DLGAP family, it also summed up that DLGAP1 is thought to be involved in SCZ starting from nucleus accumbens, AD in frontal cortex, and MDD originating from hippocampus (Rasmussen, Rasmussen, & Silahtaroglu, 2017) .
As DLGAP1 encoding protein SAPAP interacted with PSD95 encoded by DLG4, that constituted NMDA receptor-associated postsynaptic density proteins, DLG4 was reported to be a predictor of cognitive deficits (Sultana et al., 2009; Whitfield et al., 2014) , while NMDA was suggested for the association with ADHD and prefrontal dysfunction, we tested the association of DLGAP1-DLG4-NMDA pathway with cognitive flexibility and ADHD symptom. The results validated our hypothesis. NMDA dysfunction has been considered to be involved in ADHD pathogenesis for its effect on neurodevelopment, attentional circuitry, and impulse inhibition (Chang et al., 2014) . Besides, NMDA alteration (subunit expression, activity, and localization) in the PFC had also been implicated in many neuropsychiatric disorders with impairment of cognitive flexibility, including SCZ, depression, and anxiety disorders (Balu & Coyle, 2014; Belforte et al., 2010; Beneyto, Kristiansen, Oniorisan, Mccullumsmith, & Meadorwoodruff, 2007; Bitanihirwe, Lim, & Woo, 2010; Davis, 2011; Laruelle, 2014) . Decreased PSD95 expression in prefrontal cortex was also found in SCZ and MDD (Feyissa, Chandran, Stockmeier, & Karolewicz, 2009; Ohnuma et al., 2000) . These data further provide evidence for possible involvement of DLGAP1-DLG4-NMDA in cognitive flexibility and ADHD. ).
In conclusion, our study confirmed children with ADHD have cognitive flexibility and inhibition deficits contrary to the healthy control, which is associated with DLGAP1 gene. The significant SNPs and those in LD with them influenced DLGAP1 expression in wide brain regions including medulla and frontal cortex. The role of DLGAP1 seems to be modulated by the complex of DLGAPs-DLG4-NMDA to contribute to cognitive flexibility and ADHD symptom, which may provide new target for the treatment of ADHD. Further investigation into the cognitive phenotype may provide new pathway to the discovery of ADHD genes.
